American Well Corporation (AMWL)
| Market Cap | 69.25M |
| Revenue (ttm) | 265.02M |
| Net Income (ttm) | -113.43M |
| Shares Out | 16.37M |
| EPS (ttm) | -7.18 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 54,201 |
| Open | 4.180 |
| Previous Close | 4.110 |
| Day's Range | 4.100 - 4.250 |
| 52-Week Range | 3.710 - 12.950 |
| Beta | 1.28 |
| Analysts | Hold |
| Price Target | 8.33 (+96.93%) |
| Earnings Date | Nov 4, 2025 |
About AMWL
American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as offers spec... [Read more]
Financial Performance
In 2024, American Well's revenue was $254.36 million, a decrease of -1.81% compared to the previous year's $259.05 million. Losses were -$208.14 million, -69.17% less than in 2023.
Financial StatementsAnalyst Summary
According to 7 analysts, the average rating for AMWL stock is "Hold." The 12-month stock price target is $8.33, which is an increase of 96.93% from the latest price.
News
American Well Corporation (AMWL) Q3 2025 Earnings Call Transcript
American Well Corporation ( AMWL) Q3 2025 Earnings Call November 4, 2025 5:00 PM EST Company Participants Ido Schoenberg - Chairman & CEO Mark Hirschhorn - Executive VP, COO & CFO Conference Call Par...
Amwell® Announces Results for Third Quarter 2025
BOSTON , Nov. 04, 2025 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, today announced financial result...
Amwell® to report third quarter 2025 operating results; company leaders to attend upcoming investor conferences
BOSTON, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, will report third quarter 2025 op...
American Well Corporation (AMWL) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)
American Well Corporation (NYSE:AMWL) Morgan Stanley 23rd Annual Global Healthcare Conference September 9, 2025 2:35 PM EDT Company Participants Ido Schoenberg - Chairman & CEO Mark Hirschhorn - Exec...
American Well Q2 Review: Hold Rating Maintained Amid DHA Renewal Concerns
American Well's revenue growth and cost control are strong, but the short DHA contract extension raises concerns about long-term stability and reliability of key revenue streams. Amwell's shift to hig...
Amwell makes grant to new employees under inducement plan
BOSTON, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading technology-enabled care platform provider, announces that on August 8, Amwell made grants of RSUs covering an aggregate of 7...
American Well (AMWL) Q2 Revenue Up 13%
American Well (AMWL 21.02%), a major telehealth solutions provider, reported second-quarter 2025 results on August 5, 2025. The standout detail: GAAP revenue of $70.9 million in Q2 2025 outpaced analy...
American Well Corporation (AMWL) Q2 2025 Earnings Call Transcript
American Well Corporation (NYSE:AMWL) Q2 2025 Earnings Conference Call August 5, 2025 5:00 PM ET Company Participants Ido Schoenberg - Chairman & CEO Mark J. Hirschhorn - Executive VP, COO & CFO Sue ...
Amwell® Announces Results for Second Quarter 2025
BOSTON, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, today announced financial results for the seco...
Amwell set to continue to enable U.S. Defense Health Agency healthcare teams to deliver connected and seamless in-person and virtual care for the Military Health System (“MHS”)
BOSTON, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leading technology-enabled care platform provider, announced that as part of a Leidos-led partnership, it has been awarded an extensi...
Amwell® to report second quarter 2025 operating results; company leaders to attend upcoming investor conferences
BOSTON, July 22, 2025 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, will report second quarter 2025 o...
Amwell makes grant to new employee under inducement plan
BOSTON, May 06, 2025 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading technology-enabled care platform provider, announced that on May 6, Amwell made a grant of RSUs of 3,451 shares of its Class ...
American Well Corporation (AMWL) Q1 2025 Earnings Call Transcript
American Well Corporation (NYSE:AMWL) Q1 2025 Results Conference Call May 1, 2025 5:00 PM ET Company Participants Sue Dooley - Head of Investor Relations Ido Schoenberg - Chairman & Chief Executive O...
Amwell® Announces Results for First Quarter 2025
BOSTON, May 01, 2025 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL) a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, today announced financial results for the first ...
Amwell® to participate in upcoming investor conferences
BOSTON, April 24, 2025 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, will participate in the followi...
Amwell® to report first quarter 2025 operating results
BOSTON, April 17, 2025 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leader in digital care, will report first quarter 2025 operating results after stock market trading hours on Thursday, May 1 2025. F...
Amwell makes inducement grant
BOSTON, March 03, 2025 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leader in technology-enabled care, today announced that, on March 3, 2025, it made a grant of restricted stock units (“RSUs”) coveri...
Amwell announces innovation leader as chief product and technology officer
BOSTON, March 03, 2025 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leader in technology-enabled care, announced Dan Zamansky, an industry leader in innovation and technology, as the company's new chi...
Amwell® makes grants to new employees under inducement plan
BOSTON, Feb. 21, 2025 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading technology-enabled care platform provider, announced that on Feb. 18, Amwell made grants of RSUs covering an aggregate of 16...
Amwell® to participate in upcoming investor conference
BOSTON, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, will participate in an upcoming investor confe...
American Well Corporation (AMWL) Q4 2024 Earnings Call Transcript
American Well Corporation (NYSE:AMWL) Q4 2024 Earnings Conference Call February 12, 2025 5:00 PM ET Company Participants Sue Dooley - Head of Investor Relations Ido Schoenberg - Chairman & Chief Exec...
Amwell® Announces Results for Fourth Quarter and Full Year 2024
BOSTON, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, today announced financial results for the four...
Amwell® to report fourth quarter and full year 2024 operating results
BOSTON, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leader in digital care, will report fourth quarter 2024 operating results after stock market trading hours on Wednesday, Feb. 12.
Amwell® adds Vida to its clinical programs portfolio expanding access to obesity and diabetes care
BOSTON and SAN FRANCISCO, Jan. 15, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leader in digital care, today announced that Vida Health, a leader in virtual cardiometabolic care, is now part of t...
Amwell® divests virtual psychiatric care business to Avel eCare in all-cash transaction
Divestment of Amwell Psychiatric Care intended to focus product portfolio on key growth initiatives Company reiterates guidance for 2024 BOSTON, Jan. 09, 2025 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL)...